Nasdaq biol.

Larry N Feinberg, the manager of Oracle Associates, has opened a position in BIOLASE Inc (NASDAQ: BIOL).In a recent filing with the Securities and Exchange Commission, Mr. Feinberg disclosed ...IRVINE, Calif., Oct. 9, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that Dr. Elaine C. Wagner, a retired Rear Admiral with 33 years of ...FOOTHILL RANCH, Calif., Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by ...LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that its Board of Directors declared ...The Panera Bread Company is a public company that is traded on the NASDAQ stock market. The majority of its shareholders are financial institutions and mutual fund holders. The remaining shares are owned by direct holders of Panera Bread st...

Biolase Inc (NASDAQ:BIOL) is the most popular stock in this table. On the other hand WVS Financial Corp. (NASDAQ:WVFC) is the least popular one with only 1 bullish hedge fund positions.Posted by Techdows on Nov 30th, 2023. StockNews.com lowered shares of BIOLASE ( NASDAQ:BIOL – Free Report) from a hold rating to a sell rating in a report issued on Wednesday. Separately, Benchmark cut their price objective on shares of BIOLASE from $10.00 to $4.00 in a research report on Wednesday, September 20th. Get BIOLASE alerts:LAKE FOREST, Calif., June 14, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that President and Chief Executive Officer, John Beaver and ...

Mar 1, 2022 · 01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ... FOOTHILL RANCH, Calif., Aug. 16, 2021 /PRNewswire/ -- Demonstrating a deep commitment to expanding the core capabilities and diversity of its Board of Directors, BIOLASE, Inc. (NASDAQ: BIOL), the ...

Source: Kantar Media. Advertisement. Biolase Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BIOL updated stock price target summary.How much is Biolase stock worth today? ( NASDAQ: BIOL) Biolase currently has 2,296,777 outstanding shares. With Biolase stock trading at $1.25 per share, the total value of Biolase stock (market capitalization) is $2.87M. Biolase stock was originally listed at a price of $38,049.71 in Dec 31, 1997.Nov 15, 2020 · Investors in BIOLASE, Inc. (NASDAQ:BIOL) had a good week, as its shares rose 7.1% to close at US$0.29 following the release of its third-quarter results. It was a pretty bad result overall; while ... Institutional Holdings information can be used to gauge the volatility and value on the company’s stock. $173.46 -0.20. VinFast Auto Ltd. Ordinary Shares. $8.11 +0.06 +0.75%. Find the latest ...

BIOLASE, Inc. (NASDAQ:BIOL) fell 10% to $1.35 in pre-market trading. Biolase shares jumped 44% on Tuesday after the company announced Q4 preliminary sales guidance above analyst estimates..

BIOLASE, Inc. 17 Nov, 2021, 16:05 ET. FOOTHILL RANCH, Calif., Nov. 17, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote TODAY ...

BIOLASE (NASDAQ:BIOL) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the superior investment?We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten ...Confira a cotação BIOL hoje e acompanhe as ações BIOLASE em tempo real. As seções dessa página permitem ver o preço da ação agora, comparar com dados históricos, ver gráficos, dividendos e indicadores importantes sobre as ações BIOLASE Inc negociadas na Bolsa de Valores NASDAQ.Source: Kantar Media. Advertisement. Biolase Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BIOL updated stock price target summary.BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - EVC GroupJohn Beaver -...Predictive Oncology (NASDAQ: POAI) Biolase (NASDAQ: BIOL) CohBar (NASDAQ: CWBR) Vista Gold (NYSEAMERICAN: VGZ) Calyxt (NASDAQ: CLXT) Clearside Biomedical (NASDAQ: CLSD) Penny Stocks Under $3 ...Find the latest SEC Filings data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.

P/E & PEG Ratios. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the ...Spare a thought for those who held BIOLASE, Inc. (NASDAQ:BIOL) for five whole years - as the share price tanked 88%. Shareholders have had an even rougher run lately, with the share price down 46% ...Nov 18, 2023 · BIOLASE Stock Performance. Shares of BIOL stock opened at $1.25 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 1.40 and a debt-to-equity ratio of 34.06. The firm has a 50 day moving average price of $1.78 and a two-hundred day moving average price of $11.22. BIOLASE has a 12-month low of $1.07 and a 12-month high of $175.99. FOOTHILL RANCH, Calif., May 13, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its first quarter ended March 31, 2021.Jan 10, 2023 · LAKE FOREST, Calif., Jan. 10, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 shares of common stock at a public offering price of $0.35 per share or $0.34 per pre ... H.C. Wainwright initiated coverage on Korro Bio Inc (NASDAQ: KRRO), a biotech company developing genetic medicines focused …

Source: Kantar Media. Advertisement. Biolase Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BIOL updated stock price target summary.

BIOLASE Inc stock price (BIOL). NASDAQ: BIOL. Buying or selling a stock that's not traded in your local currency? Don't let the currency conversion trip you ...morningstar.com - November 1 at 12:25 PM. BIOLASE, Inc. (BIOL) ca.finance.yahoo.com - October 18 at 8:14 AM. BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants. finance.yahoo.com - September 18 at 5:11 PM.FOOTHILL RANCH, Calif., Aug. 31, 2021 /PRNewswire/ -- Today BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a clinical advisory partnership with Dr. L. Stephen Buchanan ...Gainers BIOLASE, Inc. (NASDAQ:BIOL) shares climbed 30.9% to $0.8270 after the company reported better-than-expected Q2 sales. The company said i...Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsBIOLASE (NASDAQ:BIOL) plummets 47.31% premarket on pricing of an underwritten public offering consisting of 16,453,569 shares of its common stock and pre-funded warrants to purchase 11,403,571 ...Biolase (NASDAQ:BIOL) shares dropped 11% on Wednesday after the dental lasers company reported fourth quarter results that lagged Wall Street estimates.The company generated revenue of $14.05M ...

To maintain listing, the Nasdaq Capital Market requires, among other things, that our common stock maintain a minimum closing bid price of $1.00 per share. On May 24, 2021, we received a deficiency letter from the Nasdaq Stock Market notifying us that, for the 30 consecutive business days ended May 21, 2021, the bid price for our common stock ...

Nov 18, 2023 · BIOLASE Stock Performance. Shares of BIOL stock opened at $1.25 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 1.40 and a debt-to-equity ratio of 34.06. The firm has a 50 day moving average price of $1.78 and a two-hundred day moving average price of $11.22. BIOLASE has a 12-month low of $1.07 and a 12-month high of $175.99.

BIOLASE, Inc. (NASDAQ:BIOL) reported fourth-quarter revenues of $8.52 million, down 16.3% year-over-year. The loss per share, however, narrowed from 13 cents to 7 cents. Analysts estimated a ...Source: Kantar Media. Advertisement. Biolase Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BIOL updated stock price target summary.BIOLASE's CEO is John Beaver, appointed in Feb 2021, has a tenure of 2.75 years. total yearly compensation is $733.09K, comprised of 51.2% salary and 48.8% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth $152.65. The average tenure of the management team and the board of directors is 2 years ...14 Sept 2023 ... Shares in BIOLASE Inc (NASDAQ:BIOL) fell to all time lows; falling 39.57% or 1.29 to 1.97. The CBOE Volatility Index, which measures the implied ...LAKE FOREST, Calif. , Nov. 9, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial …FOOTHILL RANCH, Calif., Feb. 4, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today received official notification from the Listing Qualifications Department .../PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will be presenting at the Benchmark Company Discovery...BIOL. BIOLASE, Inc. 1.2400. +0.0200. +1.64%. BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript March 28, 2023 Operator: Greetings. Welcome to the BIOLASE 2022 Fourth Quarter and Full ...BIOL Biolase Inc Form 8-K - Current report BIOLASE, INC false 0000811240 0000811240 2023-11-14 2023-11-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ...U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up 0.61% to 34,784.94 while the NASDAQ rose 0.71% to 13,911.78 ...

BIOL stock is up 44% year-to-date, but it’s literally a penny stock trading at about 70 cents a share, with a $101 million market cap. The stock has a B-rating in my Portfolio Grader . Best ...Graphite Bio, Inc. (Nasdaq – GRPH) Under the terms of the agreement, Graphite Bio will merge with LENZ Therapeutics in an all-stock transaction. Under the …FOOTHILL RANCH, Calif., Jan. 12, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers announced an agreement with Dental Care Alliance (DCA), one of the largest ...Instagram:https://instagram. stratasys sharear in stockbest reit for dividendshomelessness in canada Nelly Dodson. December 4, 2023. Technologies. Biolase Inc (NASDAQ:BIOL) has a beta value of 1.20 and has seen 1.07 million shares traded in the recent trading session. The company, currently valued at $3.29M, closed the recent trade at $1.43 per share which meant it gained $0.28 on the day or 24.35% during that session. lockheed martin corp stock pricetutor perini corp. FOOTHILL RANCH, Calif., Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser company, today released the following statement in response to the attempt by ...FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned ... 1933 goudey babe ruth Nov 14, 2022 · LAKE FOREST, Calif., Nov. 14, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate in the 11 th Annual ... Webull offers Biolase Inc (BIOL) historical stock prices, in-depth market analysis, NASDAQ: BIOL real-time stock quote data, in-depth charts.BIOLASE, Inc. (NASDAQ:BIOL) shares rose 40.4% to $0.674 in pre-market trading after jumping over 26% on Monday. BIOLASE, earlier during the month, announced a collaboration with BMW Performance ...